Company Filing History:
Years Active: 2005
Title: Wolf-Dieter Müller: Innovator in Allergy Therapy
Introduction
Wolf-Dieter Müller is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of immunotherapy, particularly in the area of allergy treatment. His innovative work focuses on developing modified recombinant allergens that can improve the efficacy of allergy therapies.
Latest Patents
Wolf-Dieter Müller holds a patent for "Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same." This invention relates to modified recombinant allergen mutants derived from natural raw materials, such as pollen. These modified allergens stimulate lymphocytes from allergic patients to proliferate and synthesize cytokines. However, they exhibit a significantly reduced ability to bind to IgE antibodies present in the serum of T lymphocyte donors. This characteristic allows for a more targeted and effective allergy therapy.
Career Highlights
Wolf-Dieter Müller is associated with Merck Patent Gesellschaft MIT, where he continues to advance research in allergy treatments. His work has been instrumental in developing therapies that can provide relief to individuals suffering from pollen allergies.
Collaborations
Wolf-Dieter Müller has collaborated with notable colleagues, including Helga Kahlert and Hans-Thomas Stüwe. Their combined expertise has contributed to the success of their research and innovations in the field of immunotherapy.
Conclusion
Wolf-Dieter Müller is a pioneering inventor whose work in allergy therapy has the potential to transform treatment options for patients. His innovative approach to modifying allergens represents a significant advancement in the field of immunotherapy.